Viewing Study NCT00911859

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-01-17 @ 1:33 PM
Study NCT ID: NCT00911859
Status: COMPLETED
Last Update Posted: 2014-11-18
First Post: 2009-05-29
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None CNTO328 View
None Interleukin-6 (IL-6) View
None Monoclonal antibody View
None Anti-IL-6 monoclonal antibody View
None Bortezomib View
None Velcade View
None Melphalan View
None Prednisone View